Main: +45 31 10 91 91
Fax: +45 77 31 15 09
CVR/VAT no. 31348854
Ordering: +45 29 13 42 24
Immudex is a fast-growing life science company providing solutions for cellular immune monitoring within immunotherapy, infectious disease, transplantation, and autoimmunity. Based on our proprietary Dextramer® and dCODE® technologies, we develop and market research reagents and diagnostic assays enabling researchers, developers, and clinicians to measure disease-specific immunity.
You will join the Immudex R&D department, where we work in project teams to develop new products, assays, and applications. You will be working in the laboratory on the assigned tasks from different projects together with one or more scientists. Main tasks and responsibilities revolve around development and testing of new proteins and assays to support research and development projects within R&D and Custom Project Service.
You are a laboratory technician by training or have a similar educational background, preferably with at least one year’s hands-on experience from a research laboratory. You are comfortable with recombinant protein production in E. coli, including expression, refolding, purification, and protein analysis and you are familiar with SDS-PAGE, ELISA, and FPLC (ÄKTA) analysis. Hands-on experience with molecular biology and cell culture techniques as well as cellular assays like flow cytometry, ELISpot, and other immunoassays will be an advantage.
As a person you are open-minded, have a good sense of humor and communication. You are a strong team player, but can also work independently, and you thrive with a high pace without losing track of the details. You enjoy planning and working in a flexible work environment where tasks may change from day to day.
We offer an interesting laboratory technician position with training and development opportunities in an international and diverse organization, where we care for each other and care about making a difference to human health. The position is permanent and is based at Immudex’ headquarters in Virum
We process applications on a continuous basis, which is why we encourage you to send your application and CV as soon as possible and no later than June 30, 2021, to firstname.lastname@example.org.
If you have any questions about the position, please contact:
Thomas Holberg Blicher, Senior Scientist, mob. +45 3113 7325.
Based in Copenhagen, Denmark, with North American operations based in Fairfax, Virginia, Immudex manufactures MHC Dextramer® for the detection of antigen-specific T cells. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.
Immudex' MHC Dextramer® products are utilized for the quantification or sorting of antigen-specific T cells in life science research, in-vitro diagnostics, as well as the development of immunotherapeutics and vaccines. The primary focus is research-use-only products for the immune monitoring of immunotherapy development and monitoring of CMV cellular immunity in transplant and other immune-deficient patients. In Europe, the CE-marked Dextramer® CMV Kit is approved for in vitro diagnostic use for the quantification of CMV-specific T cells. USA FDA 510(k) clearance for the CMV kit was granted March 2017. GMP Grade reagents are available.
Our state-of-the-art dCODE Dextramer® reagents enable massive multiplexing of antigen-specific T-cell detection. Detection of over 1000 CD8+ T-cell specificities from a single blood sample has been achieved.